About Precision Medicine Group
Precision Medicine Group is a company based in Bethesda (United States) founded in 2012 by Mark Clein.. Precision Medicine Group has raised $257.21 million across 4 funding rounds from investors including Blackstone, TPG and J.H. Whitney Capital Partners. The company has 2,151 employees as of December 31, 2024. Precision Medicine Group has completed 13 acquisitions, including Agility Clinical, Algorics and ApoCell. Precision Medicine Group offers products and services including Biomarker Intelligence, Global CRO, and Specialty Labs. Precision Medicine Group operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Frontage Laboratories and Veeda Clinical Research, among others.
- Headquarter Bethesda, United States
- Employees 2151 as on 31 Dec, 2024
- Founders Mark Clein
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precision Medicine Group, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$257.21 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Blackstone
& 5 more
-
Employee Count
2151
as on Dec 31, 2024
-
Investments & Acquisitions
Agility Clinical
& 12 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Medicine Group
Precision Medicine Group offers a comprehensive portfolio of products and services, including Biomarker Intelligence, Global CRO, and Specialty Labs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers data analysis for biomarker-driven drug development processes.
Provides contract research for global clinical trials and studies.
Delivers central lab and biospecimen management for research needs.
Unlock access to complete
Software Development Team
12 people
Human Resources and Administration
7 people
Leadership Team
5 people
Legal and Compliance
3 people
Sales and Marketing
2 people
Finance and Accounting
1 people
Operations Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Precision Medicine Group
Precision Medicine Group has successfully raised a total of $257.21M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(02 Apr 2013)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Private Equity Round - Precision Medicine Group | Valuation | Blackstone |
|
| Feb, 2019 | Amount | Private Equity Round - Precision Medicine Group | Valuation |
investors |
|
| Dec, 2015 | Amount | Private Equity Round - Precision Medicine Group | Valuation | TPG |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Precision Medicine Group
Precision Medicine Group has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Blackstone, TPG and J.H. Whitney Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified investment management is provided across multiple asset classes.
|
Founded Year | Domain | Location | |
|
Fund of funds focused on pre-seed and seed-stage companies
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precision Medicine Group
Precision Medicine Group has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Agility Clinical, Algorics and ApoCell. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Platform for data analytics and risk management for clinical trials
|
2013 | ||||
|
Provider of digital marketing, data solutions, and medical affair solutions for pharmaceutical industry
|
2013 | ||||
|
Provider of consulting, quality, regulatory, and marketing services to biopharma sector
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Precision Medicine Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Precision Medicine Group Comparisons
Competitors of Precision Medicine Group
Precision Medicine Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Frontage Laboratories and Veeda Clinical Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Early drug development services are provided for pharma firms.
|
|
| domain | founded_year | HQ Location |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Precision Medicine Group
Frequently Asked Questions about Precision Medicine Group
When was Precision Medicine Group founded?
Precision Medicine Group was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Precision Medicine Group located?
Precision Medicine Group is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
Who is the current CEO of Precision Medicine Group?
Mark Clein is the current CEO of Precision Medicine Group. They have also founded this company.
Is Precision Medicine Group a funded company?
Precision Medicine Group is a funded company, having raised a total of $257.21M across 4 funding rounds to date. The company's 1st funding round was a Private Equity Round of $75M, raised on Apr 02, 2013.
How many employees does Precision Medicine Group have?
As of Dec 31, 2024, the latest employee count at Precision Medicine Group is 2,151.
What does Precision Medicine Group do?
Precision Medicine Group was founded in 2012 and is headquartered in Bethesda, United States. Operations focus on the life sciences sector, where clinical research, biomarker-driven development, and commercialization services are delivered from product launch to maturity. Offerings include clinical development, specialty labs, commercial consulting, market access, and medical communications. Expertise in lab sciences, translational informatics, regulatory affairs, payer insights, and marketing communications is integrated across services.
Who are the top competitors of Precision Medicine Group?
Precision Medicine Group's top competitors include LabCorp, Charles River Laboratories and Cytel.
What products or services does Precision Medicine Group offer?
Precision Medicine Group offers Biomarker Intelligence, Global CRO, and Specialty Labs.
How many acquisitions has Precision Medicine Group made?
Precision Medicine Group has made 13 acquisitions, including Agility Clinical, Algorics, and ApoCell.
Who are Precision Medicine Group's investors?
Precision Medicine Group has 6 investors. Key investors include Blackstone, TPG, J.H. Whitney Capital Partners, Oak Investment Partners, and Ethan D. Leder.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.